Cool-To The Moon - Tiger Brokers Online Investing Community

Like
Comment
Favorite

DannyTan
2021-02-18

Cool

Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses

The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more dose

Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Top
Latest

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":384981773,"tweetId":"384981773","gmtCreate":1613606682492,"gmtModify":1704882601922,"author":{"id":3569973075109763,"idStr":"3569973075109763","authorId":3569973075109763,"authorIdStr":"3569973075109763","name":"DannyTan","avatar":"https://static.tigerbbs.com/890baf4ba6385f3e1ad178cfed1843a5","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":5,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Cool</p></body></html>","htmlText":"<html><head></head><body><p>Cool</p></body></html>","text":"Cool","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/384981773","repostId":1171944463,"repostType":4,"repost":{"id":"1171944463","pubTimestamp":1613553025,"share":"https://www.laohu8.com/m/news/1171944463?lang=&edition=full","pubTime":"2021-02-17 17:10","market":"us","language":"en","title":"Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=1171944463","media":"Bloomberg","summary":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more dose","content":"<p>The&nbsp;European Union&nbsp;finalized an agreement with&nbsp;Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.</p>\n<p>This second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.</p>\n<p>As many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first&nbsp;announced&nbsp;in January.</p>\n<p>EU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger&nbsp;foothold&nbsp;on the continent.</p>\n<p>The commission is also seeking to boost its stock of vaccines from&nbsp;Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Europe Clinches Pfizer-BioNTech Deal for 200 Million More Doses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEurope Clinches Pfizer-BioNTech Deal for 200 Million More Doses\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 17:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-02-17/europe-clinches-pfizer-biontech-deal-for-200-million-more-doses?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171944463","content_text":"The European Union finalized an agreement with Pfizer Inc. and BioNTech SE for 200 million more doses of their Covid-19 vaccine, locking in a second-quarter supply boost as countries struggle to speed up their immunization drives.\nThis second order significantly increases the number of doses available from the two companies for the bloc’s 27 member states. The contract includes a firm order for 200 million shots, with an option to request an additional 100 million, which could double the EU’s overall supply from the companies.\nAs many as 75 million doses from the order will be shipped in the second quarter, European Commission President Ursula von der Leyen said when the deal was first announced in January.\nEU countries are far behind the U.S. and U.K. in the race to vaccinate as many people as possible, even as faster-spreading variants of the virus gain a stronger foothold on the continent.\nThe commission is also seeking to boost its stock of vaccines from Moderna Inc., which, like Pfizer-BioNTech, has a shot based on messenger RNA technology. Unlike more conventional vaccines, the mRNA shots can be modified within weeks if necessary to protect against mutant versions of the virus.","news_type":1},"isVote":1,"tweetType":1,"viewCount":182,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}